scholarly article | Q13442814 |
P50 | author | Avi Orr-Urtreger | Q64761255 |
Deborah Raymond | Q64856479 | ||
Lorraine Clark | Q64858601 | ||
Karen S. Marder | Q67209635 | ||
Susan Bressman | Q67212570 | ||
Roy N Alcalay | Q67215512 | ||
Helen Mejia-Santana | Q67242979 | ||
Laurie Ozelius | Q67426010 | ||
Christina Palmese | Q114420377 | ||
LRRK2 Ashkenazi Jewish Consortium | Q114420378 | ||
Matthew J Barrett | Q56487531 | ||
Anat Mirelman | Q56769483 | ||
Nir Giladi | Q64761181 | ||
Rachel Saunders-Pullman | Q64761222 | ||
P2093 | author name string | Elise Caccappolo | |
P2860 | cites work | LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample | Q83916757 |
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study | Q29614953 | ||
Neuropathologic substrates of Parkinson disease dementia | Q30527797 | ||
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease | Q33723751 | ||
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis | Q34140991 | ||
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies | Q34513753 | ||
Changes in motor subtype and risk for incident dementia in Parkinson's disease | Q34517430 | ||
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study | Q35897974 | ||
Clinical and pathological characteristics of LRRK2 G2019S patients with PD. | Q35911042 | ||
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. | Q35938554 | ||
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study | Q36005602 | ||
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations | Q37385032 | ||
Cognitive and motor function in long-duration PARKIN-associated Parkinson disease | Q37625797 | ||
Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease | Q37679384 | ||
The neuropathology of genetic Parkinson's disease | Q37997386 | ||
LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort | Q38900613 | ||
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease | Q38902628 | ||
Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers | Q39477657 | ||
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease | Q42010008 | ||
Cognitive decline in Parkinson's disease: a prospective longitudinal study | Q44789584 | ||
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group | Q44801417 | ||
Clinical features of LRRK2-associated Parkinson's disease in central Norway | Q44830290 | ||
A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations | Q46417649 | ||
Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease | Q46849539 | ||
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism | Q48248911 | ||
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease | Q48392751 | ||
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. | Q51889070 | ||
Cognitive profile of patients with newly diagnosed Parkinson disease. | Q51987773 | ||
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. | Q54403187 | ||
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. | Q55041570 | ||
The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease | Q61881956 | ||
The effect of age of onset of PD on risk of dementia | Q61932329 | ||
P433 | issue | 2 | |
P921 | main subject | neuropsychology | Q3872 |
Parkinson's disease | Q11085 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 106-110 | |
P577 | publication date | 2014-11-20 | |
P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
P1476 | title | Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease | |
P478 | volume | 21 |
Q36885946 | A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis |
Q35850713 | Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium |
Q39206423 | Clinical Features of LRRK2 Carriers with Parkinson's Disease |
Q57072461 | Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-Analysis |
Q89776335 | Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study |
Q37305731 | Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease |
Q39967268 | Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers |
Q92933189 | LRRK2 in Parkinson disease: challenges of clinical trials |
Q38376569 | Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease |
Q39841718 | Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease |
Q35772821 | Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene |
Q90194740 | Postural Instability in Parkinson's Disease: A Review |
Q47198236 | Progression in the LRRK2-Asssociated Parkinson Disease Population |
Q36470291 | REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers |
Q91774191 | Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson's disease |
Q40783163 | The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot |
Search more.